GESSEL advised on the sale of a 75% stake in Centrum Medyczne Med-Gastr to Tar Heel Capital

GESSEL provided legal advice on a ground-breaking transaction which opens the way to consolidation of the private gastroenterology services market in Poland in which the ArKa family foundation, the majority shareholder, divested a 75% stake in Centrum Medyczne Med-Gastr sp. z o.o., a specialised medical facility providing gastroenterology services, to Tar Heel Capital (“THC”), a private equity fund focused on investments in the SME sector.

The new investor brings substantial experience in building medical entities at country level, and Med-Gastr joins the fund’s third consolidation platform in this sector. THC’s financial and strategic backing will support the clinic’s continued development and promote early diagnoses of colorectal cancer.

GESSEL’s team provided comprehensive legal support throughout the transaction. The project was a complex one, what with structuring the deal, supporting the due diligence process, and delivering legal and tax advice in connection with divestment of real estate assets. GESSEL also prepared and negotiated the transactional documentation, including post-closing corporate governance arrangements, securing the owners’ interests at every stage.

“This transaction required an unconventional approach and a great deal of determination. I am pleased that we had such a dedicated and effective legal advisor as GESSEL on our side,” said Arkadiusz Mamos, Management Board Member of the shareholder of Centrum Medyczne Med-Gastr.

“Our firm’s strength lies in its comprehensive, multidisciplinary approach to the matters entrusted to us. This transaction clearly shows that the best results for clients are achieved through synergy of diverse competencies and close collaboration of specialist teams,” said Aldona Pietrzak, Partner at GESSEL.

Clairfield International acted as financial advisor to the seller, represented by Tadeusz Madej, Piotr Rudek, and Janusz Nowak.